Health and Wellness : CANCER VACCINE

Kemetstry

going above and beyond
PREMIUM MEMBER
Feb 19, 2001
28,693
8,139
Detroit
Occupation
Chemist

Cancer ‘vaccine’ eliminates tumors in mice
Activating T cells in tumors eliminated even distant metastases in mice, Stanford researchers found. Lymphoma patients are being recruited to test the technique in a clinical trial.
med.stanford.edu




.
 

Kemetstry

going above and beyond
PREMIUM MEMBER
Feb 19, 2001
28,693
8,139
Detroit
Occupation
Chemist
Cancer ‘vaccine’ eliminates tumors in mice
Activating T cells in tumors eliminated even distant metastases in mice, Stanford researchers found. Lymphoma patients are being recruited to test the technique in a clinical trial.


Jan 31 2018


image.img.620.high.jpg

Ronald Levy (left) and Idit Sagiv-Barfi (right) led the work on a possible cancer treatment that involves injecting two immune-stimulating agents directly into solid tumors.
Steve Fisch



Injecting minute amounts of two immune-stimulating agents directly into solid tumors in mice can eliminate all traces of cancer in the animals, including distant, untreated metastases, according to a study by researchers at the Stanford University School of Medicine.
The approach works for many different types of cancers, including those that arise spontaneously, the study found.
The researchers believe the local application of very small amounts of the agents could serve as a rapid and relatively inexpensive cancer therapy that is unlikely to cause the adverse side effects often seen with bodywide immune stimulation.
“When we use these two agents together, we see the elimination of tumors all over the body,” said Ronald Levy, MD, professor of oncology. “This approach bypasses the need to identify tumor-specific immune targets and doesn’t require wholesale activation of the immune system or customization of a patient’s immune cells.”


One agent is currently already approved for use in humans; the other has been tested for human use in several unrelated clinical trials. A clinical trial was launched in January to test the effect of the treatment in patients with lymphoma.
Levy, who holds the Robert K. and Helen K. Summy Professorship in the School of Medicine, is the senior author of the study, which was published Jan. 31 in Science Translational Medicine. Instructor of medicine Idit Sagiv-Barfi, PhD, is the lead author.
‘Amazing, bodywide effects’
Levy is a pioneer in the field of cancer immunotherapy, in which researchers try to harness the immune system to combat cancer. Research in his laboratory led to the development of rituximab, one of the first monoclonal antibodies approved for use as an anticancer treatment in humans.
Some immunotherapy approaches rely on stimulating the immune system throughout the body. Others target naturally occurring checkpoints that limit the anti-cancer activity of immune cells. Still others, like the CAR T-cell therapy recently approved to treat some types of leukemia and lymphomas, require a patient’s immune cells to be removed from the body and genetically engineered to attack the tumor cells. Many of these approaches have been successful, but they each have downsides — from difficult-to-handle side effects to high-cost and lengthy preparation or treatment times.


“All of these immunotherapy advances are changing medical practice,” Levy said. “Our approach uses a one-time application of very small amounts of two agents to stimulate the immune cells only within the tumor itself. In the mice, we saw amazing, bodywide effects, including the elimination of tumors all over the animal.”
Cancers often exist in a strange kind of limbo with regard to the immune system. Immune cells like T cells recognize the abnormal proteins often present on cancer cells and infiltrate to attack the tumor. However, as the tumor grows, it often devises ways to suppress the activity of the T cells.
Levy’s method works to reactivate the cancer-specific T cells by injecting microgram amounts of two agents directly into the tumor site. (A microgram is one-millionth of a gram). One, a short stretch of DNA called a CpG oligonucleotide, works with other nearby immune cells to amplify the expression of an activating receptor called OX40 on the surface of the T cells. The other, an antibody that binds to OX40, activates the T cells to lead the charge against the cancer cells. Because the two agents are injected directly into the tumor, only T cells that have infiltrated it are activated. In effect, these T cells are “prescreened” by the body to recognize only cancer-specific proteins.


Cancer-destroying rangers
Some of these tumor-specific, activated T cells then leave the original tumor to find and destroy other identical tumors throughout the body.
The approach worked startlingly well in laboratory mice with transplanted mouse lymphoma tumors in two sites on their bodies. Injecting one tumor site with the two agents caused the regression not just of the treated tumor, but also of the second, untreated tumor. In this way, 87 of 90 mice were cured of the cancer. Although the cancer recurred in three of the mice, the tumors again regressed after a second treatment. The researchers saw similar results in mice bearing breast, colon and melanoma tumors.
I don’t think there’s a limit to the type of tumor we could potentially treat, as long as it has been infiltrated by the immune system.
Mice genetically engineered to spontaneously develop breast cancers in all 10 of their mammary pads also responded to the treatment. Treating the first tumor that arose often prevented the occurrence of future tumors and significantly increased the animals’ life span, the researchers found.
Finally, Sagiv-Barfi explored the specificity of the T cells by transplanting two types of tumors into the mice. She transplanted the same lymphoma cancer cells in two locations, and she transplanted a colon cancer cell line in a third location. Treatment of one of the lymphoma sites caused the regression of both lymphoma tumors but did not affect the growth of the colon cancer cells.


“This is a very targeted approach,” Levy said. “Only the tumor that shares the protein targets displayed by the treated site is affected. We’re attacking specific targets without having to identify exactly what proteins the T cells are recognizing.”
The current clinical trial is expected to recruit about 15 patients with low-grade lymphoma. If successful, Levy believes the treatment could be useful for many tumor types. He envisions a future in which clinicians inject the two agents into solid tumors in humans prior to surgical removal of the cancer as a way to prevent recurrence due to unidentified metastases or lingering cancer cells, or even to head off the development of future tumors that arise due to genetic mutations like BRCA1 and 2.
“I don’t think there’s a limit to the type of tumor we could potentially treat, as long as it has been infiltrated by the immune system,” Levy said.
The work is an example of Stanford Medicine’s focus on precision health, the goal of which is to anticipate and prevent disease in the healthy and precisely diagnose and treat disease in the ill.
The study’s other Stanford co-authors are senior research assistant and lab manager Debra Czerwinski; professor of medicine Shoshana Levy, PhD; postdoctoral scholar Israt Alam, PhD; graduate student Aaron Mayer; and professor of radiology Sanjiv Gambhir, MD, PhD.


Levy is a member of the Stanford Cancer Institute and Stanford Bio-X.
Gambhir is the founder and equity holder in CellSight Inc., which develops and translates multimodality strategies to image cell trafficking and transplantation.
The research was supported by the National Institutes of Health (grant CA188005), the Leukemia and Lymphoma Society, the Boaz and Varda Dotan Foundation and the Phil N. Allen Foundation.
Stanford’s Department of Medicine also supported the work.

  • conger-krista-90.jpg.img.320.high.png

    By Krista Conger
    Krista Conger is a science writer for the medical school's Office of Communication & Public Affairs. Email her at kristac@stanford.edu.
Stanford Medicine integrates research, medical education and health care at its three institutions - Stanford University School of Medicine, Stanford Health Care (formerly Stanford Hospital & Clinics), and Lucile Packard Children's Hospital Stanford. For more information, please visit the Office of Communication & Public Affairs site at http://mednews.stanford.edu.



.
 

Create an account or login to comment

You must be a member in order to leave a comment

Create account

Create an account on our community. It's easy!

Log in

Already have an account? Log in here.

Thread starter Similar threads Forum Replies Date
Kemetstry Health and Wellness : LUNG CANCER VACCINE IN CUBA? Black Health and Wellness 0
Kemetstry Health and Wellness : NEW CANCER VACCINE SHOWS PROMISE Black Health and Wellness 0
jamesfrmphilly vaccine to protect against cervical cancer Black Health and Wellness 3
Kemetstry Black Entertainment : BLACK PANTHER STAR DIES OF CANCER Black Entertainment 2
Clyde C Coger Jr Health and Wellness : Rep. John Lewis Diagnosed With Stage 4 Pancreatic Cancer Black Health and Wellness 1
Kemetstry Health and Wellness : CANCER LINKED TO HAIR DYE AND STR8ENERS Black Health and Wellness 0
Kemetstry Health and Wellness : PANCREATIC CANCER CURE? Black Health and Wellness 0
Clyde C Coger Jr Health and Wellness : New study finds cancer-causing chemicals in tap water Black Health and Wellness 0
Clyde C Coger Jr Science and Technology : Study on cannabis chemical as a treatment for pancreatic cancer may have 'major impact,' Harvard researcher says Science and Technology 0
Clyde C Coger Jr Health and Wellness : Blood pressure medicine recall expands amid cancer concerns Black Health and Wellness 2
Perfection Black Women : ▶Speaking of Black Women◀Breast Cancer Intervention-Older African American Women in Beauty Salons Black Women 0
Clyde C Coger Jr Black Positive People : Jury awards $289M to a black man who blames Roundup for cancer Black People Doing Positive Things 0
Clyde C Coger Jr Health and Wellness : Cancer Drugs probably Weren’t Tested on People of Color Black Health and Wellness 1
Kemetstry Health and Wellness : NIGERIAN STUDENT DEVELOPES BREAST CANCER CURE Black Health and Wellness 2
jamesfrmphilly Black Positive People : breast-cancer-black-women breakthrough Black People Doing Positive Things 0
Kemetstry Health and Wellness : MEN MUST EJACULATE 21 TIMES A MONTH TO PREVENT CANCER Black Health and Wellness 4
Queenie Health and Wellness : Breast Cancer Deaths INCREASING for Black Women Black Health and Wellness 1
Kemetstry Health and Wellness : NEW CANCER TREATMENT Black Health and Wellness 0
Clyde C Coger Jr Black Positive People : Physicist Hadiyah-Nicole E Green Is On The Verge Of A Cancer Treatment Breakthrough Black People Doing Positive Things 2
Clyde C Coger Jr African American History Culture : How the ancient world dealt with cancer African American History Culture 0
jamesfrmphilly Health and Wellness : baby-powder-cancer-lawsuits Black Health and Wellness 5
Clyde C Coger Jr Food Discussion : 16 Cancer Causing Foods You Should Never Eat Food Discussion and Recipes 0
Clyde C Coger Jr Food Discussion : 30 Worst Foods For Your Heart - Ginger kills Cancer Cells Food Discussion and Recipes 13
Liberty Health and Wellness : Prostate cancer surveillance criteria may not be accurate for African American men Black Health and Wellness 0
Kemetstry Health and Wellness : DARK CHOCOLATE CURE FOR PANCREATIC CANCER? Black Health and Wellness 1
Clyde C Coger Jr Food Discussion : Toast and Cancer: The Potentially Scary Link Food Discussion and Recipes 0
Clyde C Coger Jr Food Discussion : Processed Meats (and Probably Red Meats) Can Cause Cancer, Says Controversial WHO Report Food Discussion and Recipes 1
jamesfrmphilly Health and Wellness : meats cause cancer, WHO..... Black Health and Wellness 1
jamesfrmphilly Black Sports : flip saunders dies of cancer..... Black Sports 2
Liberty Health and Wellness : Kellogg's Kashi cereal found to be full of GMOs and cancer-causing glyphosate Black Health and Wellness 29
RAPTOR Health and Wellness : Read Later Share Tweet Venom of Aggressive Brazilian Wasp Rips Holes in Cancer Cells Black Health and Wellness 0
Clyde C Coger Jr Health and Wellness : 10 Foods That Destroy Cancer and Help You Live Longer Black Health and Wellness 13
Clyde C Coger Jr Health and Wellness : One Woman’s Story Highlights the Hidden Skin Cancer Risks for People of Color Black Health and Wellness 0
Kemetstry Health and Wellness : POLIO VIRUS MAY KILL BRAIN CANCER Black Health and Wellness 0
Kemetstry Health and Wellness : GINGER ROOT KILLS CANCER CELLS? Black Health and Wellness 2
Kemetstry Health and Wellness : CELERY CURES LUNG CANCER? Black Health and Wellness 2
RAPTOR Health and Wellness : Finally! The FDA Admits That Nearly Over 70% of U.S. Chickens Contain Cancer-Causing Arsenic Black Health and Wellness 0
Clyde C Coger Jr Health and Wellness : Top 6 Antioxidant Foods For Preventing Cancer Black Health and Wellness 10
Kemetstry Health and Wellness : MORE SEX LOWERS THE RISK OF PROSTRATE CANCER Black Health and Wellness 2
Kemetstry Health and Wellness : CHILDHOOD OBESITY TIED TO CANCER Black Health and Wellness 1
Kemetstry Health and Wellness : NEW CANCER DRUG APPROVED Black Health and Wellness 0
gogounited Health and Wellness : Breast Cancer and Mammograms plus other insight... Black Health and Wellness 3
Kadijah Health and Wellness : Smelling farts prevents cancer, strokes, heart attacks, arthritis, and dementia Black Health and Wellness 0
Kemetstry Health and Wellness : VASECTOMYS AND PROSTRATE CANCER LINKED Black Health and Wellness 53
jamesfrmphilly Black People : comic Paul Mooney battles prostate cancer Black People Open Forum 1
Kemetstry Health and Wellness : CRISPY FRIES LINKED TO CANCER Black Health and Wellness 16
Clyde C Coger Jr Jails / Prisons : Prisoners raise money for breast cancer awareness Law Forum - Prisons - Gun Ownership 0
Kemetstry Science and Technology : CANCER MAY BE TRANSMITTED THRU ORAL SEX Science and Technology 20
A Black People : FYI Controversial Diet To Treat Cancer, Asthma: Gerson Therapy Black People Open Forum 2
Kemetstry Science and Technology : HIV Virus May Cure Cancer? Science and Technology 4
Similar threads


















































Latest profile posts

Cheryl Fitts wrote on Destee's profile.
I am looking for participants in a study to share their experiences as former African American males served as ED/EBD/BD in the southeast. Participants ages 18-35 will be interviewed and given the opportunity to express their thoughts, feelings and impressions of their school years. If interested or for more information please contact me directly. Thanks, Cheryl
Cheryl Fitts wrote on Destee's profile.
Thank you for the welcome. I have a question. I am a doctorate student in need of participants for my study. Is it allowable to post a request for study participants. If so, this is the post that would be uploaded:
Let's us all remember in 2021 to protect our energy and to do the best we can to grow and evolve.
Queen Destee im back still showing lo e after what 20+ yrs? You know always stop through from time to time
Destee wrote on rhymebad's profile.
@rhymebad ... i love you ... :love: ... what was going wrong about polls and being blocked and stuff?
Top